Related references
Note: Only part of the references are listed.Ectopic pituitary adenoma of the TSH-secreting sphenoidal sinus with excellent response to somatostatin analogs. Theory of the embryogenesis and literature review from a clinical case
Eugenia Ortiz et al.
STEROIDS (2020)
A 2019 update on TSH-secreting pituitary adenomas
P. Beck-Peccoz et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2019)
Thyrotropin-secreting pituitary adenomas: a systematic review and meta-analysis of postoperative outcomes and management
Giulia Cossu et al.
PITUITARY (2019)
Presurgical treatment with somatostatin analogues in growth hormone-secreting pituitary adenomas: A long-term single-center experience
Liang Lv et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2018)
Prolonged preoperative treatment of acromegaly with Somatostatin analogs may improve surgical outcome in patients with invasive pituitary macroadenoma (Knosp grades 1-3): a retrospective cohort study conducted at a single center
Lian Duan et al.
BMC ENDOCRINE DISORDERS (2017)
Clinical Importance of Somatostatin Receptor 2 (SSTR2) and Somatostatin Receptor 5 (SSTR5) Expression in Thyrotropin-Producing Pituitary Adenoma (TSHoma)
Benxia Yu et al.
MEDICAL SCIENCE MONITOR (2017)
Short-term Preoperative Octreotide for Thyrotropin-secreting Pituitary Adenoma
Hong-Juan Fang et al.
CHINESE MEDICAL JOURNAL (2017)
Thyrotropin-secreting pituitary adenomas: epidemiology, diagnosis, and management
Fatemeh G. Amlashi et al.
ENDOCRINE (2016)
Short-term preoperative octreotide treatment for TSH-secreting pituitary adenoma
Noriaki Fukuhara et al.
ENDOCRINE JOURNAL (2015)
A long-term follow-up study of eighteen patients with thyrotrophin-secreting pituitary adenomas
Nadege C. van Varsseveld et al.
CLINICAL ENDOCRINOLOGY (2014)
Development of Thyroid Storm After Surgical Resection of a Thyrotropin-Secreting Pituitary Adenoma
Kathleen Page et al.
Endocrine Practice (2013)
Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in Somatotroph Adenomas Assessed by Monoclonal Antibodies Was Reduced by Octreotide and Correlated With the Acute and Long-Term Effects of Octreotide
Olivera Casar-Borota et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
2013 European Thyroid Association Guidelines for the Diagnosis and Treatment of Thyrotropin-Secreting Pituitary Tumors
P. Beck-Peccoz et al.
EUROPEAN THYROID JOURNAL (2013)
Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogues and dopastatins
Federico Gatto et al.
CLINICAL ENDOCRINOLOGY (2012)
In vivo and in vitro response to octreotide LAR in a TSH-secreting adenoma: characterization of somatostatin receptor expression and role of subtype 5
Federico Gatto et al.
PITUITARY (2011)
TSH-secreting adenomas
Paolo Beck-Peccoz et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours
Erika Hubina et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Long-term surgical outcome in 16 patients with thyrotropin pituitary adenoma
N Sanno et al.
JOURNAL OF NEUROSURGERY (2000)
Share Paper
